M. A. Abreo, N. H. Lin, D. S. Garvey, D. E. Gunn, A. M. Hettinger, J. T. Wasicak: Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors. Journal of Medicinal Chemistry, 16.2.1996, 39. vsk, nro 4, s. 817–825. PubMed:8632405doi:10.1021/jm9506884ISSN 0022-2623Artikkelin verkkoversio.
S. Ikushima, I. Muramatsu, Y. Sakakibara, K. Yokotani, M. Fujiwara: The effects of d-nicotine and l-isomer on nicotinic receptors. The Journal of Pharmacology and Experimental Therapeutics, elokuu 1982, 222. vsk, nro 2, s. 463–470. PubMed:7097565ISSN 0022-3565Artikkelin verkkoversio.
N. L. Benowitz, P. Jacob, R. T. Jones, J. Rosenberg: Interindividual variability in the metabolism and cardiovascular effects of nicotine in man. The Journal of Pharmacology and Experimental Therapeutics, toukokuu 1982, 221. vsk, nro 2, s. 368–372. PubMed:7077531ISSN 0022-3565Artikkelin verkkoversio.
Posselt, W.; Reimann, L.: Chemische Untersuchung des Tabaks und Darstellung eines eigenthümlich wirksamen Prinzips dieser Pflanze, s. 138–161. C.F. Müller, 1828. Teoksen verkkoversio (viitattu 10.3.2018). (saksa)
Posselt, W.; Reimann, L.: Chemische Untersuchung des Tabaks und Darstellung eines eigenthümlich wirksamen Prinzips dieser Pflanze. (Tupakan kemiallinen tutkimus ja tämän kasvin tunnusomaisesti aktiivisen ainesosan valmistus) Magazin für Pharmacie, 1828, 6. vsk, nro 24, s. 138–161. Artikkelin verkkoversio. (saksa)
Louis-Bernard Guyton de Morveau, Joseph Louis Gay-Lussac, Franc ois Arago, Michel Euge ne Chevreul, E. leuthe re E. lie Nicolas Mascart, Marcellin Berthelot: Annales de chimie et de physique, s. 465–479. (Katso erityisesti s. 470. Melsenin antama empiirinen kaava on väärin, sillä tuolloin kemistit käyttivät hiilelle väärää atomimassaa 6 oikean 12 sijaan) Masson., 1843. Teoksen verkkoversio (viitattu 10.3.2018). (ranska)
Suzanne L. Dickson, Emil Egecioglu, Sara Landgren, Karolina P. Skibicka, Jörgen A. Engel, Elisabet Jerlhag: The role of the central ghrelin system in reward from food and chemical drugs. Molecular and Cellular Endocrinology, 20.6.2011, 340. vsk, nro 1, s. 80–87. PubMed:21354264doi:10.1016/j.mce.2011.02.017ISSN 1872-8057Artikkelin verkkoversio.
Jack E. Henningfield, Mitch Zeller: Nicotine psychopharmacology research contributions to United States and global tobacco regulation: a look back and a look forward. Psychopharmacology, 1.2.2006, 184. vsk, nro 3–4, s. 286–291. doi:10.1007/s00213-006-0308-4ISSN 0033-3158Artikkelin verkkoversio.
Maarten Gees, Yeranddy A. Alpizar, Tomas Luyten, Jan B. Parys, Bernd Nilius, Geert Bultynck: Differential effects of bitter compounds on the taste transduction channels TRPM5 and IP3 receptor type 3. Chemical Senses, toukokuu 2014, 39. vsk, nro 4, s. 295–311. PubMed:24452633doi:10.1093/chemse/bjt115ISSN 1464-3553Artikkelin verkkoversio.
Robert West, Witold Zatonski, Magdalena Cedzynska, Dorota Lewandowska, Joanna Pazik, Paul Aveyard: Placebo-controlled trial of cytisine for smoking cessation. The New England Journal of Medicine, 29.9.2011, 365. vsk, nro 13, s. 1193–1200. PubMed:21991893doi:10.1056/NEJMoa1102035ISSN 1533-4406Artikkelin verkkoversio.
M. A. Abreo, N. H. Lin, D. S. Garvey, D. E. Gunn, A. M. Hettinger, J. T. Wasicak: Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors. Journal of Medicinal Chemistry, 16.2.1996, 39. vsk, nro 4, s. 817–825. PubMed:8632405doi:10.1021/jm9506884ISSN 0022-2623Artikkelin verkkoversio.
A. B. Elgoyhen, D. E. Vetter, E. Katz, C. V. Rothlin, S. F. Heinemann, J. Boulter: alpha10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells. Proceedings of the National Academy of Sciences of the United States of America, 13.3.2001, 98. vsk, nro 6, s. 3501–3506. PubMed:11248107doi:10.1073/pnas.051622798ISSN 0027-8424Artikkelin verkkoversio.
Noor Azuin Suliman, Che Norma Mat Taib, Mohamad Aris Mohd Moklas, Mohd Ilham Adenan, Mohamad Taufik Hidayat Baharuldin, Rusliza Basir: Establishing Natural Nootropics: Recent Molecular Enhancement Influenced by Natural Nootropic. Evidence-based Complementary and Alternative Medicine : eCAM, 2016, nro 2016. PubMed:27656235doi:10.1155/2016/4391375ISSN 1741-427XArtikkelin verkkoversio.
Konstantinos E. Farsalinos, Riccardo Polosa: Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Therapeutic Advances in Drug Safety, huhtikuu 2014, 5. vsk, nro 2, s. 67–86. PubMed:25083263doi:10.1177/2042098614524430ISSN 2042-0986Artikkelin verkkoversio.
Konstantinos E. Farsalinos, Kurt A. Kistler, Gene Gillman, Vassilis Voudris: Evaluation of Electronic Cigarette Liquids and Aerosol for the Presence of Selected Inhalation Toxins. Nicotine & Tobacco Research, 1.2.2015, 17. vsk, nro 2, s. 168–174. doi:10.1093/ntr/ntu176ISSN 1462-2203Artikkelin verkkoversio.
Joseph G. Allen, Skye S. Flanigan, Mallory LeBlanc, Jose Vallarino, Piers MacNaughton, James H. Stewart: Flavoring Chemicals in E-Cigarettes: Diacetyl, 2,3-Pentanedione, and Acetoin in a Sample of 51 Products, Including Fruit-, Candy-, and Cocktail-Flavored E-Cigarettes. Environmental Health Perspectives, 2016, 124. vsk, nro 6. doi:10.1289/ehp.1510185Artikkelin verkkoversio.
Jennifer E. Bruin, Hertzel C. Gerstein, Alison C. Holloway: Long-Term Consequences of Fetal and Neonatal Nicotine Exposure: A Critical Review. Toxicological Sciences, elokuu 2010, 116. vsk, nro 2, s. 364. PubMed:20363831doi:10.1093/toxsci/kfq103Artikkelin verkkoversio.
Hui Chen, Ross Vlahos, Steve Bozinovski, Jessica Jones, Gary P. Anderson, Margaret J. Morris: Effect of short-term cigarette smoke exposure on body weight, appetite and brain neuropeptide Y in mice. Neuropsychopharmacology, huhtikuu 2005, 30. vsk, nro 4, s. 713–719. PubMed:15508020doi:10.1038/sj.npp.1300597ISSN 0893-133XArtikkelin verkkoversio.
Nikotiini International Labour Organization. Viitattu 5.11.2016.
ingentaconnect.com
J. Le Houezec: Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: a review. The International Journal of Tuberculosis and Lung Disease, syyskuu 2003, 7. vsk, nro 9, s. 811–819. PubMed:12971663ISSN 1027-3719Artikkelin verkkoversio.
Hui Chen, Ross Vlahos, Steve Bozinovski, Jessica Jones, Gary P. Anderson, Margaret J. Morris: Effect of short-term cigarette smoke exposure on body weight, appetite and brain neuropeptide Y in mice. Neuropsychopharmacology, huhtikuu 2005, 30. vsk, nro 4, s. 713–719. PubMed:15508020doi:10.1038/sj.npp.1300597ISSN 0893-133XArtikkelin verkkoversio.
Robert West, Witold Zatonski, Magdalena Cedzynska, Dorota Lewandowska, Joanna Pazik, Paul Aveyard: Placebo-controlled trial of cytisine for smoking cessation. The New England Journal of Medicine, 29.9.2011, 365. vsk, nro 13, s. 1193–1200. PubMed:21991893doi:10.1056/NEJMoa1102035ISSN 1533-4406Artikkelin verkkoversio.
Suzanne L. Dickson, Emil Egecioglu, Sara Landgren, Karolina P. Skibicka, Jörgen A. Engel, Elisabet Jerlhag: The role of the central ghrelin system in reward from food and chemical drugs. Molecular and Cellular Endocrinology, 20.6.2011, 340. vsk, nro 1, s. 80–87. PubMed:21354264doi:10.1016/j.mce.2011.02.017ISSN 1872-8057Artikkelin verkkoversio.
Chunjian Li, Wan Teng, Qiumei Shi, Fusuo Zhang: Multiple Signals Regulate Nicotine Synthesis in Tobacco Plant. Plant Signaling & Behavior, 2007, 2. vsk, nro 4, s. 280–281. PubMed:19704681ISSN 1559-2316Artikkelin verkkoversio.
J. N. Langley: On the reaction of cells and of nerve-endings to certain poisons, chiefly as regards the reaction of striated muscle to nicotine and to curari. The Journal of Physiology, 30.12.1905, 33. vsk, nro 4–5, s. 374–413. PubMed:16992819ISSN 0022-3751Artikkelin verkkoversio.
Maarten Gees, Yeranddy A. Alpizar, Tomas Luyten, Jan B. Parys, Bernd Nilius, Geert Bultynck: Differential effects of bitter compounds on the taste transduction channels TRPM5 and IP3 receptor type 3. Chemical Senses, toukokuu 2014, 39. vsk, nro 4, s. 295–311. PubMed:24452633doi:10.1093/chemse/bjt115ISSN 1464-3553Artikkelin verkkoversio.
A. Shimada, H. Iizuka, T. Kawaguchi, T. Yanagita: [Pharmacodynamic effects of d-nicotine--Comparison with l-nicotine]. Folia Pharmacologica Japonica, heinäkuu 1984, 84. vsk, nro 1, s. 1–10. PubMed:6489864ISSN 0015-5691
S. Ikushima, I. Muramatsu, Y. Sakakibara, K. Yokotani, M. Fujiwara: The effects of d-nicotine and l-isomer on nicotinic receptors. The Journal of Pharmacology and Experimental Therapeutics, elokuu 1982, 222. vsk, nro 2, s. 463–470. PubMed:7097565ISSN 0022-3565Artikkelin verkkoversio.
Robert West, Witold Zatonski, Magdalena Cedzynska, Dorota Lewandowska, Joanna Pazik, Paul Aveyard: Placebo-controlled trial of cytisine for smoking cessation. The New England Journal of Medicine, 29.9.2011, 365. vsk, nro 13, s. 1193–1200. PubMed:21991893doi:10.1056/NEJMoa1102035ISSN 1533-4406Artikkelin verkkoversio.
M. A. Abreo, N. H. Lin, D. S. Garvey, D. E. Gunn, A. M. Hettinger, J. T. Wasicak: Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors. Journal of Medicinal Chemistry, 16.2.1996, 39. vsk, nro 4, s. 817–825. PubMed:8632405doi:10.1021/jm9506884ISSN 0022-2623Artikkelin verkkoversio.
L. M. Houlihan, Y. Slater, D. L. Guerra, J. H. Peng, Y. P. Kuo, R. J. Lukas: Activity of cytisine and its brominated isosteres on recombinant human alpha7, alpha4beta2 and alpha4beta4 nicotinic acetylcholine receptors. Journal of Neurochemistry, syyskuu 2001, 78. vsk, nro 5, s. 1029–1043. PubMed:11553677ISSN 0022-3042Artikkelin verkkoversio.
A. B. Elgoyhen, D. E. Vetter, E. Katz, C. V. Rothlin, S. F. Heinemann, J. Boulter: alpha10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells. Proceedings of the National Academy of Sciences of the United States of America, 13.3.2001, 98. vsk, nro 6, s. 3501–3506. PubMed:11248107doi:10.1073/pnas.051622798ISSN 0027-8424Artikkelin verkkoversio.
Noor Azuin Suliman, Che Norma Mat Taib, Mohamad Aris Mohd Moklas, Mohd Ilham Adenan, Mohamad Taufik Hidayat Baharuldin, Rusliza Basir: Establishing Natural Nootropics: Recent Molecular Enhancement Influenced by Natural Nootropic. Evidence-based Complementary and Alternative Medicine : eCAM, 2016, nro 2016. PubMed:27656235doi:10.1155/2016/4391375ISSN 1741-427XArtikkelin verkkoversio.
J. Rosenberg, N. L. Benowitz, P. Jacob, K. M. Wilson: Disposition kinetics and effects of intravenous nicotine. Clinical Pharmacology and Therapeutics, lokakuu 1980, 28. vsk, nro 4, s. 517–522. PubMed:7408411ISSN 0009-9236Artikkelin verkkoversio. (Arkistoitu – Internet Archive)
J. Le Houezec: Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: a review. The International Journal of Tuberculosis and Lung Disease, syyskuu 2003, 7. vsk, nro 9, s. 811–819. PubMed:12971663ISSN 1027-3719Artikkelin verkkoversio.
N. L. Benowitz, P. Jacob, R. T. Jones, J. Rosenberg: Interindividual variability in the metabolism and cardiovascular effects of nicotine in man. The Journal of Pharmacology and Experimental Therapeutics, toukokuu 1982, 221. vsk, nro 2, s. 368–372. PubMed:7077531ISSN 0022-3565Artikkelin verkkoversio.
Konstantinos E. Farsalinos, Riccardo Polosa: Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Therapeutic Advances in Drug Safety, huhtikuu 2014, 5. vsk, nro 2, s. 67–86. PubMed:25083263doi:10.1177/2042098614524430ISSN 2042-0986Artikkelin verkkoversio.
H. L. Waldum, O. G. Nilsen, T. Nilsen, H. Rørvik, V. Syversen, A. K. Sanvik: Long-term effects of inhaled nicotine. Life Sciences, 1996, 58. vsk, nro 16, s. 1339–1346. PubMed:8614291ISSN 0024-3205Artikkelin verkkoversio.
Jennifer E. Bruin, Hertzel C. Gerstein, Alison C. Holloway: Long-Term Consequences of Fetal and Neonatal Nicotine Exposure: A Critical Review. Toxicological Sciences, elokuu 2010, 116. vsk, nro 2, s. 364. PubMed:20363831doi:10.1093/toxsci/kfq103Artikkelin verkkoversio.
Hui Chen, Ross Vlahos, Steve Bozinovski, Jessica Jones, Gary P. Anderson, Margaret J. Morris: Effect of short-term cigarette smoke exposure on body weight, appetite and brain neuropeptide Y in mice. Neuropsychopharmacology, huhtikuu 2005, 30. vsk, nro 4, s. 713–719. PubMed:15508020doi:10.1038/sj.npp.1300597ISSN 0893-133XArtikkelin verkkoversio.
Chunjian Li, Wan Teng, Qiumei Shi, Fusuo Zhang: Multiple Signals Regulate Nicotine Synthesis in Tobacco Plant. Plant Signaling & Behavior, 2007, 2. vsk, nro 4, s. 280–281. PubMed:19704681ISSN 1559-2316Artikkelin verkkoversio.
J. N. Langley: On the reaction of cells and of nerve-endings to certain poisons, chiefly as regards the reaction of striated muscle to nicotine and to curari. The Journal of Physiology, 30.12.1905, 33. vsk, nro 4–5, s. 374–413. PubMed:16992819ISSN 0022-3751Artikkelin verkkoversio.
A. B. Elgoyhen, D. E. Vetter, E. Katz, C. V. Rothlin, S. F. Heinemann, J. Boulter: alpha10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells. Proceedings of the National Academy of Sciences of the United States of America, 13.3.2001, 98. vsk, nro 6, s. 3501–3506. PubMed:11248107doi:10.1073/pnas.051622798ISSN 0027-8424Artikkelin verkkoversio.
Noor Azuin Suliman, Che Norma Mat Taib, Mohamad Aris Mohd Moklas, Mohd Ilham Adenan, Mohamad Taufik Hidayat Baharuldin, Rusliza Basir: Establishing Natural Nootropics: Recent Molecular Enhancement Influenced by Natural Nootropic. Evidence-based Complementary and Alternative Medicine : eCAM, 2016, nro 2016. PubMed:27656235doi:10.1155/2016/4391375ISSN 1741-427XArtikkelin verkkoversio.
Konstantinos E. Farsalinos, Riccardo Polosa: Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Therapeutic Advances in Drug Safety, huhtikuu 2014, 5. vsk, nro 2, s. 67–86. PubMed:25083263doi:10.1177/2042098614524430ISSN 2042-0986Artikkelin verkkoversio.
National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health: The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US), 2014. Teoksen verkkoversio (viitattu 15.3.2018).
Jennifer E. Bruin, Hertzel C. Gerstein, Alison C. Holloway: Long-Term Consequences of Fetal and Neonatal Nicotine Exposure: A Critical Review. Toxicological Sciences, elokuu 2010, 116. vsk, nro 2, s. 364. PubMed:20363831doi:10.1093/toxsci/kfq103Artikkelin verkkoversio.
Joseph G. Allen, Skye S. Flanigan, Mallory LeBlanc, Jose Vallarino, Piers MacNaughton, James H. Stewart: Flavoring Chemicals in E-Cigarettes: Diacetyl, 2,3-Pentanedione, and Acetoin in a Sample of 51 Products, Including Fruit-, Candy-, and Cocktail-Flavored E-Cigarettes. Environmental Health Perspectives, 2016, 124. vsk, nro 6. doi:10.1289/ehp.1510185Artikkelin verkkoversio.
oup.com
academic.oup.com
Maarten Gees, Yeranddy A. Alpizar, Tomas Luyten, Jan B. Parys, Bernd Nilius, Geert Bultynck: Differential effects of bitter compounds on the taste transduction channels TRPM5 and IP3 receptor type 3. Chemical Senses, toukokuu 2014, 39. vsk, nro 4, s. 295–311. PubMed:24452633doi:10.1093/chemse/bjt115ISSN 1464-3553Artikkelin verkkoversio.
Konstantinos E. Farsalinos, Kurt A. Kistler, Gene Gillman, Vassilis Voudris: Evaluation of Electronic Cigarette Liquids and Aerosol for the Presence of Selected Inhalation Toxins. Nicotine & Tobacco Research, 1.2.2015, 17. vsk, nro 2, s. 168–174. doi:10.1093/ntr/ntu176ISSN 1462-2203Artikkelin verkkoversio.
sciencedirect.com
Suzanne L. Dickson, Emil Egecioglu, Sara Landgren, Karolina P. Skibicka, Jörgen A. Engel, Elisabet Jerlhag: The role of the central ghrelin system in reward from food and chemical drugs. Molecular and Cellular Endocrinology, 20.6.2011, 340. vsk, nro 1, s. 80–87. PubMed:21354264doi:10.1016/j.mce.2011.02.017ISSN 1872-8057Artikkelin verkkoversio.
H. L. Waldum, O. G. Nilsen, T. Nilsen, H. Rørvik, V. Syversen, A. K. Sanvik: Long-term effects of inhaled nicotine. Life Sciences, 1996, 58. vsk, nro 16, s. 1339–1346. PubMed:8614291ISSN 0024-3205Artikkelin verkkoversio.
Henry, Thomas Anderson: The plant alkaloids, s. 35–50. Iso-Britannia, Lontoo: J. & A. Churchill Ltd., 1949. Teoksen verkkoversio (pdf).
springer.com
link.springer.com
Jack E. Henningfield, Mitch Zeller: Nicotine psychopharmacology research contributions to United States and global tobacco regulation: a look back and a look forward. Psychopharmacology, 1.2.2006, 184. vsk, nro 3–4, s. 286–291. doi:10.1007/s00213-006-0308-4ISSN 0033-3158Artikkelin verkkoversio.
J. Rosenberg, N. L. Benowitz, P. Jacob, K. M. Wilson: Disposition kinetics and effects of intravenous nicotine. Clinical Pharmacology and Therapeutics, lokakuu 1980, 28. vsk, nro 4, s. 517–522. PubMed:7408411ISSN 0009-9236Artikkelin verkkoversio. (Arkistoitu – Internet Archive)
L. M. Houlihan, Y. Slater, D. L. Guerra, J. H. Peng, Y. P. Kuo, R. J. Lukas: Activity of cytisine and its brominated isosteres on recombinant human alpha7, alpha4beta2 and alpha4beta4 nicotinic acetylcholine receptors. Journal of Neurochemistry, syyskuu 2001, 78. vsk, nro 5, s. 1029–1043. PubMed:11553677ISSN 0022-3042Artikkelin verkkoversio.
ascpt.onlinelibrary.wiley.com
J. Rosenberg, N. L. Benowitz, P. Jacob, K. M. Wilson: Disposition kinetics and effects of intravenous nicotine. Clinical Pharmacology and Therapeutics, lokakuu 1980, 28. vsk, nro 4, s. 517–522. PubMed:7408411ISSN 0009-9236Artikkelin verkkoversio. (Arkistoitu – Internet Archive)
Suzanne L. Dickson, Emil Egecioglu, Sara Landgren, Karolina P. Skibicka, Jörgen A. Engel, Elisabet Jerlhag: The role of the central ghrelin system in reward from food and chemical drugs. Molecular and Cellular Endocrinology, 20.6.2011, 340. vsk, nro 1, s. 80–87. PubMed:21354264doi:10.1016/j.mce.2011.02.017ISSN 1872-8057Artikkelin verkkoversio.
J. N. Langley: On the reaction of cells and of nerve-endings to certain poisons, chiefly as regards the reaction of striated muscle to nicotine and to curari. The Journal of Physiology, 30.12.1905, 33. vsk, nro 4–5, s. 374–413. PubMed:16992819ISSN 0022-3751Artikkelin verkkoversio.
Jack E. Henningfield, Mitch Zeller: Nicotine psychopharmacology research contributions to United States and global tobacco regulation: a look back and a look forward. Psychopharmacology, 1.2.2006, 184. vsk, nro 3–4, s. 286–291. doi:10.1007/s00213-006-0308-4ISSN 0033-3158Artikkelin verkkoversio.
Maarten Gees, Yeranddy A. Alpizar, Tomas Luyten, Jan B. Parys, Bernd Nilius, Geert Bultynck: Differential effects of bitter compounds on the taste transduction channels TRPM5 and IP3 receptor type 3. Chemical Senses, toukokuu 2014, 39. vsk, nro 4, s. 295–311. PubMed:24452633doi:10.1093/chemse/bjt115ISSN 1464-3553Artikkelin verkkoversio.
A. Shimada, H. Iizuka, T. Kawaguchi, T. Yanagita: [Pharmacodynamic effects of d-nicotine--Comparison with l-nicotine]. Folia Pharmacologica Japonica, heinäkuu 1984, 84. vsk, nro 1, s. 1–10. PubMed:6489864ISSN 0015-5691
S. Ikushima, I. Muramatsu, Y. Sakakibara, K. Yokotani, M. Fujiwara: The effects of d-nicotine and l-isomer on nicotinic receptors. The Journal of Pharmacology and Experimental Therapeutics, elokuu 1982, 222. vsk, nro 2, s. 463–470. PubMed:7097565ISSN 0022-3565Artikkelin verkkoversio.
Robert West, Witold Zatonski, Magdalena Cedzynska, Dorota Lewandowska, Joanna Pazik, Paul Aveyard: Placebo-controlled trial of cytisine for smoking cessation. The New England Journal of Medicine, 29.9.2011, 365. vsk, nro 13, s. 1193–1200. PubMed:21991893doi:10.1056/NEJMoa1102035ISSN 1533-4406Artikkelin verkkoversio.
M. A. Abreo, N. H. Lin, D. S. Garvey, D. E. Gunn, A. M. Hettinger, J. T. Wasicak: Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors. Journal of Medicinal Chemistry, 16.2.1996, 39. vsk, nro 4, s. 817–825. PubMed:8632405doi:10.1021/jm9506884ISSN 0022-2623Artikkelin verkkoversio.
L. M. Houlihan, Y. Slater, D. L. Guerra, J. H. Peng, Y. P. Kuo, R. J. Lukas: Activity of cytisine and its brominated isosteres on recombinant human alpha7, alpha4beta2 and alpha4beta4 nicotinic acetylcholine receptors. Journal of Neurochemistry, syyskuu 2001, 78. vsk, nro 5, s. 1029–1043. PubMed:11553677ISSN 0022-3042Artikkelin verkkoversio.
A. B. Elgoyhen, D. E. Vetter, E. Katz, C. V. Rothlin, S. F. Heinemann, J. Boulter: alpha10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells. Proceedings of the National Academy of Sciences of the United States of America, 13.3.2001, 98. vsk, nro 6, s. 3501–3506. PubMed:11248107doi:10.1073/pnas.051622798ISSN 0027-8424Artikkelin verkkoversio.
Noor Azuin Suliman, Che Norma Mat Taib, Mohamad Aris Mohd Moklas, Mohd Ilham Adenan, Mohamad Taufik Hidayat Baharuldin, Rusliza Basir: Establishing Natural Nootropics: Recent Molecular Enhancement Influenced by Natural Nootropic. Evidence-based Complementary and Alternative Medicine : eCAM, 2016, nro 2016. PubMed:27656235doi:10.1155/2016/4391375ISSN 1741-427XArtikkelin verkkoversio.
J. Rosenberg, N. L. Benowitz, P. Jacob, K. M. Wilson: Disposition kinetics and effects of intravenous nicotine. Clinical Pharmacology and Therapeutics, lokakuu 1980, 28. vsk, nro 4, s. 517–522. PubMed:7408411ISSN 0009-9236Artikkelin verkkoversio. (Arkistoitu – Internet Archive)
J. Le Houezec: Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: a review. The International Journal of Tuberculosis and Lung Disease, syyskuu 2003, 7. vsk, nro 9, s. 811–819. PubMed:12971663ISSN 1027-3719Artikkelin verkkoversio.
N. L. Benowitz, P. Jacob, R. T. Jones, J. Rosenberg: Interindividual variability in the metabolism and cardiovascular effects of nicotine in man. The Journal of Pharmacology and Experimental Therapeutics, toukokuu 1982, 221. vsk, nro 2, s. 368–372. PubMed:7077531ISSN 0022-3565Artikkelin verkkoversio.
Konstantinos E. Farsalinos, Riccardo Polosa: Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Therapeutic Advances in Drug Safety, huhtikuu 2014, 5. vsk, nro 2, s. 67–86. PubMed:25083263doi:10.1177/2042098614524430ISSN 2042-0986Artikkelin verkkoversio.
H. L. Waldum, O. G. Nilsen, T. Nilsen, H. Rørvik, V. Syversen, A. K. Sanvik: Long-term effects of inhaled nicotine. Life Sciences, 1996, 58. vsk, nro 16, s. 1339–1346. PubMed:8614291ISSN 0024-3205Artikkelin verkkoversio.
Konstantinos E. Farsalinos, Kurt A. Kistler, Gene Gillman, Vassilis Voudris: Evaluation of Electronic Cigarette Liquids and Aerosol for the Presence of Selected Inhalation Toxins. Nicotine & Tobacco Research, 1.2.2015, 17. vsk, nro 2, s. 168–174. doi:10.1093/ntr/ntu176ISSN 1462-2203Artikkelin verkkoversio.
Hui Chen, Ross Vlahos, Steve Bozinovski, Jessica Jones, Gary P. Anderson, Margaret J. Morris: Effect of short-term cigarette smoke exposure on body weight, appetite and brain neuropeptide Y in mice. Neuropsychopharmacology, huhtikuu 2005, 30. vsk, nro 4, s. 713–719. PubMed:15508020doi:10.1038/sj.npp.1300597ISSN 0893-133XArtikkelin verkkoversio.